Vivos Therapeutics VVOS
NASDAQ VVOS
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Return on Sales [ROS] (2020 - 2026)

Updated

Vivos Therapeutics' Return on Sales [ROS] came in at -93.63% for Q2 2026, up 33.72 percentage points from -127.36% a year earlier and up 35.04 percentage points from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vivos Therapeutics reported Return on Sales [ROS] of -107.92%, down 9.03 percentage points year-over-year; for FY2025, it came in at -114.05%, down 39.73 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of -21.90 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -74.32% in FY2024 (+51.00 pp), -125.32% in FY2023 (+30.89 pp), -156.21% in FY2022 (-35.50 pp) and -120.71% in FY2021 (-28.56 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -182.19% (Q1 2022) to -47.76% (Q2 2024).
  • Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of -7.88 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2024 (a gain of 85.29 percentage points), and the weakest in Q4 2025 (a drop of 91.01 percentage points).
  • Business Quant data shows VVOS's Return on Sales [ROS] at -128.67% (Q1 2026), -166.89% (Q4 2025) and -69.79% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 Vivos Therapeutics 2.18 Mn -7.03 Mn 2.95 Mn -93.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -93.63%
Mar 31, 2026 -128.67%
Dec 31, 2025 -166.89%
Sep 30, 2025 -69.79%
Jun 30, 2025 -127.36%
Mar 31, 2025 -129.91%
Dec 31, 2024 -75.88%
Sep 30, 2024 -68.52%
Jun 30, 2024 -47.76%
Mar 31, 2024 -110.70%
Dec 31, 2023 -127.25%
Sep 30, 2023 -110.27%
Jun 30, 2023 -133.05%
Mar 31, 2023 -129.76%
Dec 31, 2022 -153.49%
Sep 30, 2022 -127.34%
Jun 30, 2022 -166.44%
Mar 31, 2022 -182.19%
Dec 31, 2021 -168.66%
Sep 30, 2021 -121.05%
API Access

Vivos Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VVOS&period=max&api_key=YOUR_API_KEY